Medical research

Signaling pathway could be key to improved osteoporosis treatment

A molecular signaling pathway identified by an international research team could be the basis of improved treatment for osteoporosis. In their report published in the online journal Nature Communications, the investigators ...

Medical research

Osteoporosis: Antibody crystallized

Inhibiting a protein called Sclerostin could probably help treating the bone-loss disease osteoporosis. New findings at the University of Würzburg could stimulate this research.

Arthritis & Rheumatism

Serotonin deficiency implicated in rheumatoid arthritis

For the first time, serotonin (5-hydroxytryptamine, 5-HT) has been directly implicated in the pathophysiology of rheumatoid arthritis (RA). Although 5-HT is predominantly known as a neurotransmitter within the central nervous ...

Diseases, Conditions, Syndromes

IOF urges early evaluation of fracture risk in diabetics

Despite an up to six-fold increased risk of broken bones in patients with type 1 diabetes mellitus (T1DM), the relationship between diabetes and osteoporosis has, until recently, suffered from a general lack of attention ...

Diseases, Conditions, Syndromes

Critically ill patients at long-term risk for bone fracture

One year after being hospitalized in intensive care, patients have reduced bone mass that puts them at greater risk for fractures, according to a new study published online ahead of print in the American Journal of Respiratory ...

Oncology & Cancer

Microenvironment provides growth factor for metastasis

Healthy bone is continuously involved in a dynamic process that includes bone deposition and bone resorption. However, when a person has cancer that spreads to the bone and bone marrow, the tissue becomes increasingly fragile, ...

page 4 from 7